The FLS (Fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of diseases, ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), which carries a significant risk of progression to cirrhosis and hepatocellular carcinoma. Since NASH is a progressive but reversible co...

Descripción completa

Detalles Bibliográficos
Autores principales: Semba, Toshihisa, Nishimura, Motoi, Nishimura, Satomi, Ohara, Osamu, Ishige, Takayuki, Ohno, Sayaka, Nonaka, Ken, Sogawa, Kazuyuki, Satoh, Mamoru, Sawai, Setsu, Matsushita, Kazuyuki, Imazeki, Fumio, Yokosuka, Osamu, Nomura, Fumio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729543/
https://www.ncbi.nlm.nih.gov/pubmed/23875831
http://dx.doi.org/10.1186/1471-230X-13-120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3729543/
https://www.ncbi.nlm.nih.gov/pubmed/23875831
http://dx.doi.org/10.1186/1471-230X-13-120

Ejemplares similares